Quick Answer
Eloxx Pharmaceuticals, Inc. reported Stockholders Equity of -$11.91 million for fiscal year 2025.
Eloxx Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$11.91M | +51.1% |
| 2024 | -$24.34M | -7.7% |
| 2023 | -$22.60M | -112.0% |
| 2022 | -$10.66M | -147.6% |
| 2021 | $22.38M | +118.8% |
| 2020 | $10.23M | -71.8% |
| 2019 | $36.21M | -15.6% |
| 2018 | $42.91M | +100.9% |
| 2017 | $21.36M | +2351.9% |
| 2017 | $871.2K | +42.8% |
| 2016 | $610.0K | -86.6% |
| 2016 | $4.56M | +609.3% |
| 2015 | $643.0K | -94.7% |
| 2015 | $12.22M | +340.5% |
| 2014 | $2.77M | -89.9% |
| 2014 | $27.49M | +626.1% |
| 2013 | $3.79M | +9.6% |
| 2012 | $3.45M | -23.6% |
| 2011 | $4.52M | -43.4% |
| 2010 | $7.98M | +40.8% |
| 2009 | $5.67M | -42.4% |
| 2008 | $9.84M | +265.7% |
| 2007 | $2.69M | -8.9% |
| 2006 | $2.95M | -47.2% |
| 2005 | $5.59M | +18.2% |
| 2004 | $4.73M | +65.6% |
| 2003 | $2.86M | -40.3% |
| 2002 | $4.79M | +2415.1% |
| 2001 | -$206.7K | -113.6% |
| 2000 | $1.52M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$20.05M | -302.4% | -7.8% |
| June 30, 2023 | -$18.60M | -1126.3% | -214.1% |
| March 31, 2023 | $16.29M | +39.4% | +252.8% |
| December 31, 2022 | -$10.66M | -147.6% | -114.0% |
| September 30, 2022 | -$4.98M | -115.1% | -374.9% |
| June 30, 2022 | $1.81M | -95.5% | -84.5% |
| March 31, 2022 | $11.69M | +324.9% | -47.8% |
| December 31, 2021 | $22.38M | +118.8% | -32.2% |
- Eloxx Pharmaceuticals, Inc. showed an increase of +51.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2000–2025 period, Eloxx Pharmaceuticals, Inc.’s stockholders equity has declined by 884.1% (from $1.52 million to -$11.91 million).
- The most recent figure is from Eloxx Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: